Neoplastic cells from BPDCN patients express pDC specific molecules, such as BDCA2, CD123, CD4, TCL1, Bcl11A, CD2AP and Spi B (Petrella and Facchetti, 2010). Here, CD4 is linked to CD4+/CD56+ hematodermic neoplasm.